Medlive Technology Co., Ltd.
Symbol: 2192.HK
HKSE
8.66
HKDMarknadspris idag
23.2180
P/E-tal
0.2136
PEG-kvot
6.30B
MRK Aktiekapital
- 0.02%
DIV Avkastning
{{företagets_namn}} (2192-HK) Finansiella rapporter
Balansräkning
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 17632.85 | 4400.9 | 4216.9 | 3908.7 | ||||||
balance-sheet.row.short-term-investments | 127.15 | 42.6 | 29.6 | 29.6 | ||||||
balance-sheet.row.net-receivables | 581.29 | 155.9 | 124.2 | 95.9 | ||||||
balance-sheet.row.inventory | 0.62 | 0.1 | 0.2 | 0.1 | ||||||
balance-sheet.row.other-current-assets | 229.63 | 58.3 | 35.4 | 33 | ||||||
balance-sheet.row.total-current-assets | 18279.8 | 4572.6 | 4351.7 | 4013 | ||||||
balance-sheet.row.property-plant-equipment-net | 45.37 | 11.1 | 14.6 | 16.9 | ||||||
balance-sheet.row.goodwill | 726.41 | 192.5 | 111.5 | 69.7 | ||||||
balance-sheet.row.intangible-assets | 152.99 | 66.7 | 24.3 | 9.3 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 879.4 | 259.3 | 135.9 | 79 | ||||||
balance-sheet.row.long-term-investments | 233.75 | 42.4 | 63.2 | -29.3 | ||||||
balance-sheet.row.tax-assets | 17.98 | 8.5 | 8.3 | 6.3 | ||||||
balance-sheet.row.other-non-current-assets | 96.83 | 0 | 29.6 | 29.6 | ||||||
balance-sheet.row.total-non-current-assets | 1273.32 | 321.2 | 251.5 | 102.6 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.account-payables | 36.9 | 14.8 | 2.7 | 6.2 | ||||||
balance-sheet.row.short-term-debt | 8.87 | 4.5 | 5.1 | 4.2 | ||||||
balance-sheet.row.tax-payables | 46.5 | 25.7 | 35.2 | 31.6 | ||||||
balance-sheet.row.long-term-debt-total | 15.72 | 3.6 | 6.1 | 9 | ||||||
Deferred Revenue Non Current | -7.54 | -7.5 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10.66 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 770 | 175 | 124.9 | 102.8 | ||||||
balance-sheet.row.total-non-current-liabilities | 168.82 | 58.8 | 38.6 | 30.2 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 33.45 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.total-liab | 980.04 | 248.6 | 171.3 | 143.4 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 39 | ||||||
balance-sheet.row.common-stock | 0.18 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 1070.8 | 284.9 | 175.3 | 75.6 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 5901.59 | 4597.3 | 308.1 | -39 | ||||||
balance-sheet.row.other-total-stockholders-equity | 11434.72 | -284.9 | 3917.6 | 3873 | ||||||
balance-sheet.row.total-stockholders-equity | 18407.29 | 4597.4 | 4401 | 3948.7 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 19553.12 | 4893.8 | 4603.2 | 4115.6 | ||||||
balance-sheet.row.minority-interest | 165.8 | 47.8 | 30.9 | 23.5 | ||||||
balance-sheet.row.total-equity | 18573.09 | 4645.2 | 4431.9 | 3972.2 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 19553.12 | - | - | - | ||||||
Total Investments | 318.26 | 42.4 | 92.8 | 0.3 | ||||||
balance-sheet.row.total-debt | 24.58 | 8.2 | 11.3 | 13.2 | ||||||
balance-sheet.row.net-debt | -17438.47 | -4350.1 | -4176 | -3865.9 |
Kassaflödesanalys
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 242.3 | 242.3 | 135 | 69.9 | ||||||
cash-flows.row.depreciation-and-amortization | 9.21 | 0 | 9 | 6.1 | ||||||
cash-flows.row.deferred-income-tax | -19.3 | 0 | 0 | -13.7 | ||||||
cash-flows.row.stock-based-compensation | 10.41 | 10.4 | 17.2 | 14.3 | ||||||
cash-flows.row.change-in-working-capital | 15.77 | 0 | -9.6 | -27.9 | ||||||
cash-flows.row.account-receivables | -16.32 | 0 | -25.1 | -31.7 | ||||||
cash-flows.row.inventory | 0.1 | 0 | -0.1 | -0.1 | ||||||
cash-flows.row.account-payables | 0.17 | 0 | 25.1 | 31.7 | ||||||
cash-flows.row.other-working-capital | 31.98 | 0 | -9.5 | -27.8 | ||||||
cash-flows.row.other-non-cash-items | -175.83 | -252.7 | -74.5 | -4.4 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 101.87 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.acquisitions-net | -56.39 | 0 | -42.6 | -53 | ||||||
cash-flows.row.purchases-of-investments | -5.65 | 0 | -3579.7 | -5.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 1.58 | 0 | 0.7 | 5.3 | ||||||
cash-flows.row.other-investing-activites | -577.8 | 0 | 43.5 | 4.4 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | -634.95 | 0 | -3585.6 | -50.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -5 | -6.5 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 4033.1 | ||||||
cash-flows.row.common-stock-repurchased | -0.68 | 0 | 5 | 0 | ||||||
cash-flows.row.dividends-paid | -124.69 | 0 | -12.1 | -92 | ||||||
cash-flows.row.other-financing-activites | -7.76 | 0 | -10.2 | -142.6 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -133.13 | 0 | -22.4 | 3792.1 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 63.06 | 0 | 329.9 | -53.9 | ||||||
cash-flows.row.net-change-in-cash | 1308.37 | 0 | -3200.9 | 3732 | ||||||
cash-flows.row.cash-at-end-of-period | 6009.58 | 678.2 | 678.2 | 3879.1 | ||||||
cash-flows.row.cash-at-beginning-of-period | 4701.21 | 678.2 | 3879.1 | 147.1 | ||||||
cash-flows.row.operating-cash-flow | 101.87 | 0 | 77.2 | 44.4 | ||||||
cash-flows.row.capital-expenditure | -0.75 | 0 | -7.5 | -2 | ||||||
cash-flows.row.free-cash-flow | 101.12 | 0 | 69.7 | 42.5 |
Resultaträkning rad
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 412 | 412 | 314.1 | 284.4 | ||||||
income-statement-row.row.cost-of-revenue | 160.67 | 160.7 | 101.3 | 83.7 | ||||||
income-statement-row.row.gross-profit | 251.34 | 251.3 | 212.7 | 200.7 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 54.26 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 141.3 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.operating-expenses | 182.51 | 173.6 | 143.4 | 126.9 | ||||||
income-statement-row.row.cost-and-expenses | 343.18 | 334.2 | 244.7 | 210.7 | ||||||
income-statement-row.row.interest-income | 184.31 | 183.9 | 66.2 | 7.7 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 32.78 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | -8.9 | -8 | -0.7 | ||||||
income-statement-row.row.total-operating-expenses | 188 | 188.1 | 0.2 | -0.4 | ||||||
income-statement-row.row.interest-expense | 0.22 | 0.4 | 0.5 | 0.5 | ||||||
income-statement-row.row.depreciation-and-amortization | 3.91 | 9.4 | 9 | 6.1 | ||||||
income-statement-row.row.ebitda-caps | 69.05 | - | - | - | ||||||
income-statement-row.row.operating-income | 65.14 | 65 | 134.8 | 70.3 | ||||||
income-statement-row.row.income-before-tax | 253.13 | 253.1 | 135 | 69.9 | ||||||
income-statement-row.row.income-tax-expense | 1.37 | 1.4 | 8.6 | 24.7 | ||||||
income-statement-row.row.net-income | 242.3 | 242.3 | 117.3 | 40.6 |
Ofta ställda frågor
Vad är Medlive Technology Co., Ltd. (2192.HK) totala tillgångar?
Medlive Technology Co., Ltd. (2192.HK) totala tillgångar är 4893816000.000.
Vad är företagets årliga omsättning?
Den årliga intäkten är 238498000.000.
Vad är företagets vinstmarginal?
Företagets vinstmarginal är 0.610.
Vad är företagets fria kassaflöde?
Fritt kassaflöde är 0.138.
Vad är företagets nettovinstmarginal?
Nettovinstmarginalen är 0.588.
Vad är företagets totala intäkter?
Totala intäkter är 0.158.
Vad är Medlive Technology Co., Ltd. (2192.HK) nettovinst (nettoinkomst)?
Nettovinst (nettoinkomst) är 242301000.000.
Vad är företagets totala skuldsättning?
Den totala skulden är 8192000.000.
Vad är rörelsens kostnader?
Rörelsens kostnader är 173579000.000.
Vad är företagets kassaflöde?
Företagets kassa är 4358255000.000.